Spyre Therapeutics Appoints Dr. Sheldon Sloan as Chief Medical Officer PR Newswire Oct 1, 2024 12:00pm
Spyre Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update PR Newswire Aug 7, 2024 8:05pm
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors GlobeNewswire Jul 18, 2024 12:00pm